Cara Therapeutics Reports First Quarter 2014 Financial Results

[GlobeNewswire] – SHELTON, Conn. — Cara Therapeutics, Inc. , a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid … more

View todays social media effects on CARA

View the latest stocks trending across Twitter. Click to view dashboard

See who Cara is hiring next, click here to view